Peripheral neuropathy decisions — 2025

The Board remands the claims for service connection for spinal stenosis, peripheral neuropathy, and bilateral lower extremity radiculopathy to correct pre-decisional duty to assist errors.

The Board denied service connection for various conditions and a TDIU, as the evidence did not support a finding that any of these disabilities were related to the Veteran's military service.

The Board denied a rating greater than 70 percent for PTSD, granted an earlier effective date of August 14, 2024, for the grant of a 70 percent rating for PTSD, and denied other claims including entitlement to an effective date prior to April 3, 2025, for the grant of a 100 percent rating evaluation for CAD.

The Veteran's claim for special monthly compensation SMC(s) was denied as there is no reasonable possibility that any of his service-connected disabilities alone prevent substantially gainful employment.

The Board granted two clothing allowances for the 2022 calendar year based on use of a right knee brace and ketoconazole shampoo 2%, but denied a clothing allowance based on use of pantoprazole.

The Veteran withdrew the appeals for entitlement to a rating in excess of 20 percent for diabetic peripheral neuropathy of both lower extremities.

The Board denied service connection for pneumonia and remanded the claims for iodine allergy, pilonidal cyst, sulfa allergy, heart disability, acquired psychiatric disorder, and lower and upper extremity disabilities.

The Board granted service connection for obstructive sleep apnea, diabetes mellitus, type II, left eye diabetic retinopathy, left foot diabetic peripheral neuropathy, right foot diabetic peripheral neuropathy, and coronary artery disease, as well as the Veteran's cause of death.

The Board denied service connection for a psychiatric disorder and left upper extremity neurological disability, finding no evidence of in-service incurrence or aggravation and no nexus to the Veteran's active duty service.

The Veteran is granted special monthly compensation (SMC) at the R(1) rate due to his need for regular aid and attendance.

The Board remands the claims for service connection for right and left lower extremity neuropathy, as well as lung cancer, due to a need for further evidence through VA examinations.

The Board granted an increased disability rating of 30 percent, but not higher, for the Veteran's service-connected left ulnar disability.

The Board granted an earlier effective date of May 25, 2017, for the award of service connection for bilateral lower extremity peripheral neuropathy and denied initial ratings in excess of 10 percent for both conditions.

The appeals for service connection for various conditions were dismissed due to the Veteran's death.

The Board remands the claims for service connection for sleep apnea, type II diabetes, diabetic peripheral neuropathy of both lower extremities, left and right knee disabilities, and left and right foot plantar fasciitis to obtain additional medical evidence.

The Veteran withdrew his claims for service connection for a lumbar spine disorder, diabetes mellitus, and bilateral diabetic neuropathy.

The Board remands the veteran's claims for a higher rating and compensation under 38 U.S.C. § 1151 due to concerns regarding the qualifications of the VA examiner.

The Board remands the claims for service connection due to insufficient evidence and the need for additional medical opinions.

The Board denied service connection for an acquired psychiatric disorder, bilateral peripheral neuropathy of the lower extremities, and skeletal arthritis as there was no evidence to support a finding that these conditions were incurred in or aggravated by active military service.

The Board denied service connection for various conditions, including herniation and bulging disk L4 through S1, knee pain with osteoarthritis, an acquired psychiatric disorder, cubital tunnel syndrome, carpal tunnel syndrome, and neuropathy. However, the Board granted a 30 percent evaluation for chronic headaches.